Lichtenburg Nut Company Business Plan — Risk Analysis
Aflatoxin events, groundnut price and supply, listing risk and the cash absorbed through the ramp, with trigger points.
Section 19 of 37
Risk Analysis
Jump to section
- 0. Basis of Preparation and Important Notice
- 1. Executive Summary
- 2. Investment Thesis
- 3. The Company
- 4. Problem, Customer Need and Value Proposition
- 5. Products and Services
- 6. Industry Analysis
- 7. Market Analysis
- 8. Customer Analysis
- 9. Competitive Landscape
- 10. Business Model
- 11. Go-to-Market Strategy
- 12. Operating Model
- 13. Raw Material Supply and Contract Farming
- 14. Quality, Food Safety and Aflatoxin Control
- 15. Management and Organisation
- 16. Strategic Plan
- 17. SWOT Analysis and Strategic Implications
- 18. Risk Analysis
- 19. ESG and Development Impact
- 20. Implementation Roadmap
- 21. Financial Model and Assumptions
- 22. Projected Income Statement
- 23. Projected Balance Sheet
- 24. Projected Cash Flow
- 25. Capital Expenditure
- 26. Working Capital
- 27. Funding Requirement and Structure
- 28. Debt Serviceability
- 29. Break-even Analysis
- 30. Scenario and Sensitivity Analysis
- 31. Valuation and Investment Returns
- 32. Key Performance Indicators and Management Dashboard
- 33. Conclusion and Recommendation
- A. Appendix A: Detailed Assumption Register
- B. Appendix B: Ten-Year Financial Summary
- C. Appendix C: Glossary and Sources
18.1 Prioritised risk register
Table 43. Prioritised risk register with mitigation and ownership
|
ID |
Risk |
P |
I |
Rating |
Mitigation |
Owner |
|---|---|---|---|---|---|---|
|
R1 |
Aflatoxin exceedance reaching the market, triggering a recall |
Med-High |
Severe |
Critical |
Nine-point control architecture (Section 14); internal action limit of 6 ppb against a 10 ppb legal limit; positive release; recall insurance; quarterly mock recalls |
Quality Manager |
|
R2 |
Loss of the anchor private label contract |
Medium |
Severe |
Critical |
Multi-year agreement with notice and transition protection; industrial pipeline developed from month 1; own brand launched by month 24 to reduce dependence |
Commercial Manager |
|
R3 |
Groundnut crop failure or price spike |
High |
Major |
Critical |
75% of kernels contracted pre-season; four months of storage cover; 25% spot allocation; quality-linked grower pricing to secure delivery priority. No hedging instrument exists. |
Supply Chain Manager |
|
R4 |
Slower volume ramp than plan |
Med-High |
Major |
High |
R40m revolving facility absorbs a shortfall of up to about 15%; capital phased so that Phases 2 and 3 can be deferred; switching analysis shows EBITDA survives a 34% shortfall |
Managing Director |
|
R5 |
Retailer margin, rebate and settlement pressure |
High |
Moderate |
High |
Board-approved floor price; mix shift toward industrial and own brand; contractual protection within tender periods |
Commercial Manager |
|
R6 |
Incumbent price response resetting category price points |
Medium |
Major |
High |
Compete on audit outcome rather than price; accept lower utilisation over unprofitable volume |
Board |
|
R7 |
dtic APSS grant not awarded |
Medium |
Moderate |
Medium |
Application submitted and adjudicated before financial close as a condition precedent; downside case models half the grant and the stress case none |
Finance Director |
|
R8 |
Municipal electricity or water interruption |
Med-High |
Moderate |
Medium |
250 kWp solar, standby generation sized to chilling and laboratory loads, 48 hours of water storage, dual-fuel roaster |
Operations Manager |
|
R9 |
Interest rate increase |
Medium |
Moderate |
Medium |
A 200 bp increase adds roughly R2m a year to finance cost; the base case is priced at a 10.50% prime rate |
Finance Director |
|
R10 |
Reversal or dilution of the 20% import duty |
Low |
Major |
Medium |
Monitor the ITAC review cycle; the business must be viable at prices 6% to 9% below plan, which the switching analysis indicates it marginally is |
Managing Director |
|
R11 |
Failure to recruit or retain the executive team |
Low-Med |
Moderate |
Medium |
Management equity at 10% plus a 5% incentive scheme; relocation support; appointments as a condition precedent |
Board |
|
R12 |
Withdrawal or non-renewal of the working capital facility |
Low |
Severe |
Medium |
Annual renewal negotiated ahead of the intake season; covenant headroom monitored monthly; alternative facility mandated as a contingency |
Finance Director |
|
R13 |
Foreign exchange exposure on imported equipment |
Medium |
Moderate |
Medium |
Forward cover taken on equipment orders at the time of placement; approximately 55% of Phase 1 plant is imported |
Finance Director |
|
R14 |
Construction cost overrun or delay |
Medium |
Moderate |
Medium |
7% contingency within Phase 1; fixed-price installation contracts where available; the downside case models a 7% capital overrun |
Operations Manager |